In-hospital mortality and major complication rates in unmatched and propensity score-matched groups
| Unmatched group | Propensity-matched group | |||||
|---|---|---|---|---|---|---|
| Control (n=2101) | High-dose methylprednisolone (n=824) | p Value | Control (n=812) | High-dose methylprednisolone (n=812) | p Value | |
| In-hospital mortality (n (%)) | 71 (3.4) | 23 (2.8) | 0.485 | 24 (3.0) | 23 (2.8) | 0.884 |
| Major complications (n (%)) | 191 (9.1) | 151 (18.3) | <0.001 | 96 (11.8) | 144 (17.7) | 0.001 |
| Respiratory complications | 84 (4.0) | 53 (6.4) | 0.006 | 39 (4.8) | 49 (6.0) | 0.324 |
| Urinary tract infection | 52 (2.5) | 29 (3.5) | 0.133 | 32 (3.9) | 29 (3.6) | 0.698 |
| Sepsis | 16 (0.8) | 10 (1.2) | 0.273 | 6 (0.7) | 10 (1.2) | 0.330 |
| Gastrointestinal ulcer/bleeding | 66 (3.1) | 71(8.6) | <0.001 | 31 (3.8) | 68 (8.4) | <0.001 |
| Pulmonary embolism | 1 (0.05) | 4 (0.5) | 0.024 | 1 (0.1) | 4 (0.5) | 0.218 |
| Length of stay (median (IQR)) | 16 (6–37) | 27 (10–52) | <0.001 | 23 (8–46) | 26 (10–52) | <0.001 |